早孕期超声预测孕晚期胎盘植入谱系疾病超声分期及手术结局的价值
回顾性分析187例前置胎盘且有剖宫产或子宫手术史孕妇的早孕期(5–7周)超声图像,评估孕囊位置与既往剖宫产瘢痕的关系。早孕期三个超声标志物(COS-1、孕囊种植于龛、孕囊位于子宫中线以下)均独立与孕晚期PAS3及不良手术结局相关,三者组合形成「高危PAS三角」可能有助于预测风险,但需大队列前瞻性研究验证。
要点
- 早孕期COS-1、孕囊种植于龛、孕囊位于子宫中线以下可预测孕晚期PAS3。
- 孕囊位于子宫中线以下的孕妇孕晚期PAS3比例达100%(95%CI 93.4–100%)。
- 三个早孕期标志物组合成「高危PAS三角」可能有助于分层手术风险。
关键影像表现/征象
- 早孕期COS-1者中79.6%(95%CI 67.1–88.2%)孕晚期为PAS3。
- 早孕期孕囊种植于既往剖宫产瘢痕龛内者中94.4%(95%CI 84.9–98.1%)孕晚期为PAS3。
- 早孕期孕囊位于子宫中线以下者中100%(95%CI 93.4–100%)孕晚期为PAS3。
诊断标准与关键数值
- COS-1预测PAS3的AUC为0.94(95%CI 0.91–0.97)。
- 孕囊种植于龛预测PAS3的AUC为0.92(95%CI 0.89–0.96)。
- 孕囊位于子宫中线以下预测PAS3的AUC为0.92(95%CI 0.88–0.96)。
- 多因素逻辑回归中COS-1(OR 7.9,95%CI 4.0–15.5;P<0.001)、孕囊种植于龛(OR 29.1,95%CI 8.1–104;P<0.001)、孕囊位于子宫中线以下(OR 38.1,95%CI 12.0–121;P<0.001)独立与PAS3相关;产次(P=0.4)和既往剖宫产次数(P=0.5)不相关。
- 不良手术结局见于22/187例妊娠,在COS-1(P<0.001)、孕囊种植于龛(P<0.001)、孕囊位于子宫中线以下(P<0.001)者中更常见。
临床应用与阅片要点
- 对有剖宫产或子宫手术史的前置胎盘孕妇,早孕期(5–7周)超声可评估孕囊与剖宫产瘢痕的关系以预测孕晚期PAS分期。
- 早孕期三个标志物组合形成「高危PAS三角」,可能便于直观预测剖宫产瘢痕妊娠和PAS风险。
- 多因素逻辑回归显示孕晚期PAS3(OR 4.3,95%CI 2.1–17.3)及早孕期COS-1(OR 7.9,95%CI 4.0–15.5)、孕囊种植于龛(OR 29.1,95%CI 8.1–79.0)、孕囊位于子宫中线以下(OR 6.6,95%CI 3.9–16.2)独立与不良手术结局相关。
局限性
- 原文指出「高危PAS三角」需在大型前瞻性研究中验证。
- 原文为回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore whether early first-trimester ultrasound can predict the third-trimester sonographic stage of placenta accreta spectrum (PAS) disorder and to elucidate whether combining first-trimester ultrasound findings with the sonographic stage of PAS disorder can stratify the risk of adverse surgical outcome in women at risk for PAS disorder.
METHODS: This was a retrospective analysis of prospectively collected data from women with placenta previa, and at least one previous Cesarean delivery (CD) or uterine surgery, for whom early first-trimester (5-7 weeks' gestation) ultrasound images could be retrieved. The relationship between the position of the gestational sac and the prior CD scar was assessed using three sonographic markers for first-trimester assessment of Cesarean scar (CS) pregnancy, reported by Calí et al. (crossover sign (COS)), Kaelin Agten et al. (implantation of the gestational sac on the scar vs in the niche of the CS) and Timor-Tritsch et al. (position of the center of the gestational sac below vs above the midline of the uterus), by two different examiners blinded to the final diagnosis and clinical outcome. The primary aim of the study was to explore the association between first-trimester ultrasound findings and the stage of PAS disorder on third-trimester ultrasound. Our secondary aim was to elucidate whether the combination of first-trimester ultrasound findings and sonographic stage of PAS disorder can predict surgical outcome. Logistic regression analysis and area under the receiver-operating-characteristics curve (AUC) were used to analyze the data.
RESULTS: One hundred and eighty-seven women with vasa previa were included. In this cohort, 79.6% (95% CI, 67.1-88.2%) of women classified as COS-1, 94.4% (95% CI, 84.9-98.1%) of those with gestational-sac implantation in the niche of the prior CS and 100% (95% CI, 93.4-100%) of those with gestational sac located below the uterine midline, on first-trimester ultrasound, were affected by the severest form of PAS disorder (PAS3) on third-trimester ultrasound. On multivariate logistic regression analysis, COS-1 (odds ratio (OR), 7.9 (95% CI, 4.0-15.5); P < 0.001), implantation of the gestational sac in the niche (OR, 29.1 (95% CI, 8.1-104); P < 0.001) and location of the gestational sac below the midline of the uterus (OR, 38.1 (95% CI, 12.0-121); P < 0.001) were associated independently with PAS3, whereas parity (P = 0.4) and the number of prior CDs (P = 0.5) were not. When translating these figures into diagnostic models, first-trimester diagnosis of COS-1 (AUC, 0.94 (95% CI, 0.91-0.97)), pregnancy implantation in the niche (AUC, 0.92 (95% CI, 0.89-0.96)) and gestational sac below the uterine midline (AUC, 0.92 (95% CI, 0.88-0.96)) had a high predictive accuracy for PAS3. There was an adverse surgical outcome in 22/187 pregnancies and it was more common in women with, compared to those without, COS-1 (P < 0.001), gestational-sac implantation in the niche (P < 0.001) and gestational-sac position below the uterine midline (P < 0.001). On multivariate logistic regression analysis, third-trimester ultrasound diagnosis of PAS3 (OR, 4.3 (95% CI, 2.1-17.3)) and first-trimester diagnosis of COS-1 (OR, 7.9 (95% CI, 4.0-15.5); P < 0.001), pregnancy implantation in the niche (OR, 29.1 (95% CI, 8.1-79.0); P < 0.001) and position of the sac below the uterine midline (OR, 6.6 (95% CI, 3.9-16.2); P < 0.001) were associated independently with adverse surgical outcome. When combining the sonographic coordinates of the three first-trimester imaging markers, we identified an area we call high-risk-for-PAS triangle, which may enable an easy visual perception and application of the three methods to prognosticate the risk for CS pregnancy and PAS disorder, although it requires validation in large prospective studies.
CONCLUSIONS: Early first-trimester sonographic assessment of pregnancies with previous CD can predict reliably ultrasound stage of PAS disorder. Combination of findings on first-trimester ultrasound with second- and third-trimester ultrasound examination can stratify the surgical risk in women affected by a PAS disorder. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Calí G, Timor-Tritsch IE, Forlani F, et al. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol. 2020. PMID: 31788885. doi:10.1002/uog.21939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。